Cite
HARVARD Citation
Inoue, M. et al. (2018). Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants. Human vaccines & immunotherapeutics. 14 (9), pp. 2150-2157. [Online].